ZA966663B - Traf Inhibitors. - Google Patents

Traf Inhibitors.

Info

Publication number
ZA966663B
ZA966663B ZA9606663A ZA966663A ZA966663B ZA 966663 B ZA966663 B ZA 966663B ZA 9606663 A ZA9606663 A ZA 9606663A ZA 966663 A ZA966663 A ZA 966663A ZA 966663 B ZA966663 B ZA 966663B
Authority
ZA
South Africa
Prior art keywords
traf
inhibitors
trafs
pharmaceuticals
nucleic acid
Prior art date
Application number
ZA9606663A
Other languages
English (en)
Inventor
David V Goeddel
Mike Rothe
Original Assignee
Genentech Inc
Tularik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Tularik Inc filed Critical Genentech Inc
Publication of ZA966663B publication Critical patent/ZA966663B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9606663A 1995-08-17 1996-08-06 Traf Inhibitors. ZA966663B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US238295P 1995-08-17 1995-08-17

Publications (1)

Publication Number Publication Date
ZA966663B true ZA966663B (en) 1998-02-06

Family

ID=21700513

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9606663A ZA966663B (en) 1995-08-17 1996-08-06 Traf Inhibitors.

Country Status (13)

Country Link
US (6) US5789550A (xx)
EP (2) EP1568708A3 (xx)
JP (2) JP4382878B2 (xx)
AT (1) ATE291585T1 (xx)
AU (1) AU709535B2 (xx)
CA (1) CA2227174A1 (xx)
DE (1) DE69634512T2 (xx)
DK (1) DK0845005T3 (xx)
ES (1) ES2239334T3 (xx)
IL (1) IL122980A0 (xx)
NZ (1) NZ315514A (xx)
WO (1) WO1997007134A1 (xx)
ZA (1) ZA966663B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA966663B (en) * 1995-08-17 1998-02-06 Genentech Inc Traf Inhibitors.
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
JP4138013B2 (ja) * 1996-12-23 2008-08-20 イミュネックス・コーポレーション Ｔｎｆスーパーファミリーのメンバーであるｎｆ−ｋａｐｐａ ｂの受容体アクティベーターに対するリガンド
US6723517B1 (en) * 1998-06-02 2004-04-20 Minerva Biotechnologies Corporation Use of self-assembled monolayers to probe the structure of a target molecule
WO1999067380A1 (en) * 1998-06-22 1999-12-29 Temple University - Of The Commonwealth System Of Higher Education c-Cbl SUPPRESSION OF NEOPLASTIC TRANSFORMATION
EP1218506A1 (en) * 1999-09-23 2002-07-03 Rigel Pharmaceuticals, Inc. Traf4 associated cell cycle proteins, compositions and methods of use
WO2002064786A1 (fr) * 2001-02-15 2002-08-22 Mochida Pharmaceutical Co., Ltd. Nouveau gene tcif
WO2002098458A1 (en) * 2001-06-07 2002-12-12 Medvet Science Pty Ltd Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity
NZ530765A (en) 2001-06-26 2006-11-30 Amgen Fremont Inc Antibodies that bind OPGL and compositions and methods for the treatment of bone diseases
US20030083304A1 (en) * 2001-10-09 2003-05-01 Smart Robert C. CCAAT/enhancer binding protein-beta (C/EBPbeta) is a molecular target for cancer treatment
IL145918A0 (en) * 2001-10-14 2002-07-25 Ares Trading Sa Method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells
WO2004012673A2 (en) * 2002-08-01 2004-02-12 Wyeth, Methods and reagents relating to inflammation and apoptosis
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
CA2682730A1 (en) * 2007-04-11 2008-10-23 Alcon Research, Ltd. Use of an inhibitor of tnf.alpha. plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
WO2009143141A1 (en) * 2008-05-19 2009-11-26 Case Western Reserve University Method for treating cd40-mediated diseases
US10669345B2 (en) * 2008-05-19 2020-06-02 Case Western Reserve University Method for treating CD40-mediated diseases
RU2011134857A (ru) 2009-01-21 2013-02-27 Вертекс Фармасьютикалз Инкорпорейтед Способы амплификации нуклеиновых кислот вируса гепатита с
BR112012007091A2 (pt) * 2009-10-01 2016-04-19 Alcon Res Ltd composições de olopatadina e seus usos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3613167A1 (de) * 1986-04-18 1987-10-29 Basf Ag Verwendung von tnf zur herstellung von arzneimitteln
US5108901A (en) 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
EP0417563B1 (de) * 1989-09-12 2000-07-05 F. Hoffmann-La Roche Ag TNF-bindende Proteine
US5318890A (en) 1991-05-06 1994-06-07 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
WO1996020723A1 (en) * 1994-12-30 1996-07-11 Brigham & Women's Hospital Controlling traf-mediated signals
ZA966663B (en) * 1995-08-17 1998-02-06 Genentech Inc Traf Inhibitors.

Also Published As

Publication number Publication date
US6060303A (en) 2000-05-09
EP1568708A3 (en) 2005-10-12
WO1997007134A1 (en) 1997-02-27
US6294348B1 (en) 2001-09-25
US6063585A (en) 2000-05-16
US5789550A (en) 1998-08-04
ATE291585T1 (de) 2005-04-15
AU709535B2 (en) 1999-09-02
EP0845005B1 (en) 2005-03-23
AU6723796A (en) 1997-03-12
JPH11511967A (ja) 1999-10-19
MX9800995A (es) 1998-10-31
US6004553A (en) 1999-12-21
EP0845005A1 (en) 1998-06-03
NZ315514A (en) 1998-12-23
DE69634512D1 (de) 2005-04-28
JP2009065981A (ja) 2009-04-02
CA2227174A1 (en) 1997-02-27
IL122980A0 (en) 1998-08-16
EP1568708A2 (en) 2005-08-31
DE69634512T2 (de) 2006-02-09
ES2239334T3 (es) 2005-09-16
DK0845005T3 (da) 2005-08-01
JP4382878B2 (ja) 2009-12-16
US20040087774A1 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
ZA966663B (en) Traf Inhibitors.
HU9600692D0 (en) Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds
IL112873A (en) Rapamycin-fkbp12 binding proteins, their isolation and their use
GR3032635T3 (en) Drug binding protein
NO960767D0 (no) Protocadherinproteiner og deres anvendelse
WO1998030694A3 (en) TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b)
AU1689297A (en) Chemokine receptors 88-2B(CKR-3) and 88C and their antibodies
EP0832973A3 (en) GTP-binding protein
DK0962531T3 (da) Interferon-gammaproduktion inducerende isoleret polypeptidfragment og et isolaret DNA-fragment der koder for dette polypeptid
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
EP1566440A3 (en) Human Interleukin-11 Receptor
MXPA01006006A (es) Cadena receptora de citocina.
GR3036782T3 (en) Proteases capable of shedding the soluble TNF-receptor and TNF-R derived peptides and antibodies against the proteases inhibiting the shedding.
DK0901526T3 (da) Cortistatin: neuropeptider, sammensætninger og metoder
FR2687687B1 (fr) Procede pour mesurer la taille de fragments d'adn.
DE69504795D1 (de) Methoden zur synthese und reinigung von peptiden
EP0897011A3 (en) Novel arginine deiminase
IL139272A0 (en) New peptide fragments for protein purification
WO2001021794A3 (en) Smad associating polypeptides